|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2003-6-24
|
|
pubmed:abstractText |
[(18)F] Fluoro-2-deoxyglucose positron emission tomography (FDG PET) has recently been established as a sensitive and specific method of detecting lymph node metastases in newly diagnosed cervical cancer. Little is known about the efficacy of PET for detecting recurrent disease. We evaluated the potential role of FDG PET in the context of suspected recurrent cervical cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0090-8258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
90
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
186-90
|
|
pubmed:dateRevised |
2010-3-23
|
|
pubmed:meshHeading |
pubmed-meshheading:12821362-Adult,
pubmed-meshheading:12821362-Aged,
pubmed-meshheading:12821362-Female,
pubmed-meshheading:12821362-Fluorine Radioisotopes,
pubmed-meshheading:12821362-Fluorodeoxyglucose F18,
pubmed-meshheading:12821362-Humans,
pubmed-meshheading:12821362-Middle Aged,
pubmed-meshheading:12821362-Neoplasm Recurrence, Local,
pubmed-meshheading:12821362-Radiopharmaceuticals,
pubmed-meshheading:12821362-Sensitivity and Specificity,
pubmed-meshheading:12821362-Tomography, Emission-Computed,
pubmed-meshheading:12821362-Uterine Cervical Neoplasms
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The role of PET scanning in the detection of recurrent cervical cancer.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27710, USA. havri001@mc.duke.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|
